{"id":"W2794768733","doi":"10.1093/schbul/sby015.234","title":"O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA","year":2018,"lang":"en","type":"article","venue":"Schizophrenia Bulletin","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Positive and Negative Syndrome Scale; Partial agonist; Adjunctive treatment; Clinical endpoint; Placebo; Psychology; Medicine; Schizophrenia (object-oriented programming); Adverse effect; Relapse prevention; Clinical Global Impression; Internal medicine; Randomized controlled trial; Psychiatry; Pharmacology; Agonist; Psychosis; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00165739,0.0004010595,0.0009953941,0.0001795763,0.0004228734,0.0004824865,0.0003536098,0.0009086936,0.01029021],"category_scores_gemma":[0.001724841,0.0002034685,0.0008496248,0.0002169361,0.0003033578,0.0005028548,0.0002833607,0.0009642039,0.001637414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004359529,"about_ca_system_score_gemma":0.0006722926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009747252,"about_ca_topic_score_gemma":0.004207593,"domain_scores_codex":[0.9992585,0.0003042659,0.0000899664,0.00008599665,0.0001705819,0.00009077307],"domain_scores_gemma":[0.9988087,0.0002540361,0.0004429083,0.00006999524,0.0001919224,0.000232428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3843289,0.007448121,0.038828,0.005010418,0.001069134,0.0007652276,0.0005060808,0.0005142387,0.0695866,0.0003340291,0.01048826,0.481121],"study_design_scores_gemma":[0.09920404,0.3829784,0.4562907,0.00131563,0.002107991,0.002005322,0.0005947602,0.002195585,0.01670134,0.0005535496,0.03592645,0.0001263366],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9629422,0.01849981,0.0008574149,0.001097222,0.0001997423,0.001930089,0.003969288,0.0001933111,0.01031089],"genre_scores_gemma":[0.9867568,0.00372217,0.001391006,0.0013194,0.0001749629,0.0006778426,0.002025871,0.0000133716,0.003918685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01029021,"threshold_uncertainty_score":0.03442419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005770614132853032,"score_gpt":0.2278070177356498,"score_spread":0.2220364036027968,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}